SCHEMBL6037895

SCHEMBL6037895

CN(Cc1ccc(CCCNC(=O)COCc2ccc(F)cc2)cc1)c1cn(C)c2ccccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.47
KMT2A Q03164 5/20 0.47
LMNA P02545 2/20 0.46
TP53 P04637 2/20 0.46
RXFP1 Q9HBX9 1/20 0.46
RAB9A P51151 2/20 0.41
ALDH1A1 P00352 1/20 0.38
POLB P06746 2/20 0.38
PDPK1 O15530 1/20 0.38
CHEK2 O96017 1/20 0.38
ABL1 P00519 1/20 0.38
EGFR P00533 1/20 0.38
ERBB2 P04626 1/20 0.38
NTRK1 P04629 1/20 0.38
MET P08581 1/20 0.38
PDGFRB P09619 1/20 0.38
KIT P10721 1/20 0.38
FGFR1 P11362 1/20 0.38
SRC P12931 1/20 0.38
PDGFRA P16234 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6038078 0.82 MEN1 (0.42) MEN1KMT2ARAB9AALDH1A1POLB
SCHEMBL6037898 0.82 TP53 (0.58) MEN1KMT2ALMNATP53RXFP1
SCHEMBL6038103 0.77 SPR (0.48) MEN1KMT2ARAB9AMAPT
SCHEMBL5325209 0.73 LMNA (0.51) MEN1KMT2ALMNARAB9AALDH1A1
SCHEMBL6038137 0.73 ACHE (0.48) MEN1KMT2AMAPT
SCHEMBL6038027 0.73 NAMPT (0.56) KMT2APOLBMAPT
SCHEMBL6037915 0.72 LMNA (0.50) MEN1KMT2ALMNARAB9AALDH1A1
SCHEMBL5277774 0.72 LMNA (0.51) MEN1KMT2ALMNARAB9AALDH1A1
SCHEMBL6038163 0.71 LMNA (0.49) MEN1KMT2ALMNARAB9AALDH1A1
SCHEMBL6038064 0.71 LMNA (0.49) MEN1KMT2ALMNARAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060264415-A1 Inhibitors of histone deacetylase METHYLGENE INC. 2006-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060264415-A1 Inhibitors of histone deacetylase HDAC1, HDAC3, HDAC11 MEN1 2348/4885KMT2A 30/4885LMNA 851/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.